Aug 12, 2020
NDA Partners in Conjunction with RJR Consulting and Intrinsik Supports Successful CTA Approval by Health Canada for First-in-Human Clinical Study
Jun 23, 2020
Nobilis Therapeutics Announces IND Filing for a Phase 2b Clinical Trial of NBTX-001 Drug/Device Combination for Treatment of Panic Disorder
Jun 22, 2020
FDA In Brief: FDA Launches New Export Certification Application System for Animal Products
Jun 22, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Jun 19, 2020
TBRC Reports: Production of New Insulin Biosimilars is The Latest Trend in The Market, as Seen With Biocon's Newly FDA Approved Semglee
Jun 19, 2020
FDA In Brief: FDA Warns Consumers to Avoid Certain Store Brand Packaged and Labeled "Garden Salad" Products from Three Retailers in Midwest Due to Cyclospora
Jun 18, 2020
Aethlon Announces FDA Approval of IDE Supplement for COVID-19 Patients
Jun 18, 2020
FDA Takes Additional Action to Harness Real-World Data to Inform COVID-19 Response Efforts
Jun 16, 2020
Quartesian Announces Amyndas Partnership for COVID-19 Clinical Trial
Jun 16, 2020
Keith Ward, Ph.D. Joins as the Chief Development Officer of Unicycive
Jun 16, 2020
FDA Warns Four Manufacturers of Unapproved Injectable Drugs Labeled as Homeopathic
Jun 16, 2020
Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chembio Antibody Test
Jun 16, 2020
Coronavirus (COVID-19) Update: Daily Roundup
Jun 15, 2020
Soliton Reports Positive Pivotal Cellulite Clinical Trial Results
Jun 15, 2020
International Isotopes Inc. is Pleased to Announce the Addition of Dr. James R. Miles, to our Drug Product Manufacturing Team
Jun 15, 2020
OTC Drugs, Medical Devices and Diagnostics: Global Markets
Jun 15, 2020
FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD
Jun 15, 2020
Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use
Jun 11, 2020
CNS Announces the FDA has Granted Orphan Drug Designation for Brain Cancer Drug Berubicin
Jun 10, 2020
Vivera Pharmaceuticals Files First of Two US Made COVID-19 Antibody Tests